Therapy of chronic hepatitis C with PEG-IFN α-2b plus ribavirin in patients with genotype 2 or 3-Reference-Cited by-同舟云学术

Therapy of chronic hepatitis C with PEG-IFN α-2b plus ribavirin in patients with genotype 2 or 3

Published:2013-12 Issue:12 Volume:25 Page:1396-1401
ISSN:0954-691X
Container-title:European Journal of Gastroenterology & Hepatology
language:en
Short-container-title:

Author:

Fabris Paolo,Carlotto Antonio,Bianco Tiziana Del,Malfatti Federica,Tramarin Andrea,Miotti Marco A.,Baldo Vincenzo,Floreani Annarosa,Giordani Maria Teresa,Grasso Alessandro

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference6 articles.

1. Short-term therapy for patients with hepatitis C virus genotype 2 or 3 infection.;Dalgard;Drugs,2006

2. Short-term treatment duration for HCV-2 and HCV-3 infected patients.;Andriulli;Dig Liver Dis,2006

3. Optimal length of antiviral therapy in patients with hepatitis C virus genotype 2 and genotype 3: a meta-analysis.;Slavemburg;Antivir Ther,2008

4. In patients with HCV genotype 2 or 3 infection and RVR 14 weeks treatment is noninferior to 24 weeks. Pooled analysis of two Scandinavian trials.;Dalgard;Eur J Gastroenterol Hepatol,2010

5. Easy to treat genotypes were not created equal: Can rapid virological response (RVR) level the playing field.;Duarte-Rojo;J Hepatol,2011

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcome of hepatitis C patients in a community with predominant genotype 3 with standard-of-care treatment before and after advent of direct-acting antivirals: A retrospective-cum-prospective study;Indian Journal of Pharmacology;2020

2. Investigating the Generalizability of Economic Evaluations Conducted in Italy: A Critical Review;Value in Health;2015-07

3. Update on the treatment of hepatitis C genotypes 2–6;Current Opinion in Infectious Diseases;2014-12